[3H]ATPA: A high affinity ligand for GluR5 kainate receptors

Neuropharmacology

Volumn 38, Issue 12, 1999, Pages 1811-1817

  Hoo, Ken ^a   Legutko, Beatta ^b,e   Rizkalla, Geihan ^a   Deverill, Michele ^a   Hawes, C R ^c   Ellis, Gareth J ^c   Stensbol, Tine B ^d   Krogsgaard Larsen, Povl ^d   Skolnick, Phil ^b   Bleakman, David ^b  

^a NPS Pharmaceutical Inc   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c GENERAL ELECTRIC COMPANY   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Agonist; DRG neurons; Kainate receptors

Indexed keywords

2 AMINO 3 (3 HYDROXY 5 TERT BUTYLISOXAZOL 4 YL)PROPANOIC ACID; 6 (4 CARBOXYBENZYL) 1,2,3,4,4A,5,6,7,8,8A DECAHYDRO 3 ISOQUINOLINECARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DOMOIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR AGONIST; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; RADIOLIGAND; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; ALPHA AMINO 3 HYDROXY 5 TERT BUTYL 4 ISOXAZOLEPROPIONATE; ALPHA-AMINO-3-HYDROXY-5-TERT-BUTYL-4-ISOXAZOLEPROPIONATE; AMINO ACID RECEPTOR STIMULATING AGENT; GLUR5 KAINATE RECEPTOR; ISOXAZOLE DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG SYNTHESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRAARTICULAR DRUG ADMINISTRATION; NERVE CELL MEMBRANE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION; ANIMAL; GENETICS; METABOLISM; NERVE CELL;

ANIMALS; ANIMALS, NEWBORN; CELL LINE; EXCITATORY AMINO ACID AGONISTS; GANGLIA, SPINAL; HUMANS; ISOXAZOLES; KAINIC ACID; NEURONS; PROPIONATES; RATS; RECEPTORS, KAINIC ACID;

EID: 0032585753     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00133-1     Document Type: Article

References (35)

1. Bahn S., Volk B., Wisden W. Kainate receptor gene expression in the developing rat brain. J. Neurosci. 14:1994;5525-5547.
2. Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A., Deneris E.S., Moll C., Borgmeyer U., Hollmann M., Heinemann S. Cloning of a novel glutamate receptor subunit, GluR5: expression in the central nervous system during development. Neuron. 5:1990;583-595.
3. Bettler B., Egebjerg J., Sharma G., Pecht G., Herman-Borgmeyer I., Moll C., Stevens C.F., Heinemann S. Cloning of a putative glutamate receptor: a low affinity kainate binding subunit. Neuron. 8:1992;257-265.
4. Bleakman D., Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 37:1998;1187-1204.
5. Bleakman D., Schoepp D.D., Ballyk B., Bufton H., Sharpe E.F., Thomas K., Ornstein P.L., Kamboj R.K. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S, 4aR, 6R, 8aR)-6-[2-(1 (2) H-tetrazole-5-yl ethyl] decahydroisoquinoline-3 carboxylic acid. Mol. Pharmacol. 49:1996;581-585.
6. Clarke V.R.J., Ballyk B.A., Hoo K.H., Mandelzys A., Pellizzari A., Bath C.P., Thomas J., Sharpe E.F., Davies C.H., Ornstein P.L., Schoepp D.D., Kamboj R.K., Collingridge G.L., Lodge D., Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389:1997;599-603.
7. Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature. 351:1991;745-748.
8. Fletcher E.J., Lodge D. New developments in the molecular pharmacology of AMPA and kainate receptors. Pharmacol. Ther. 70:1996;65-89.
9. Gu Z.-Q., Hesson D., Pelletier J., Maccechini M.-L., Zhou L.-M., Skolnick P. Synthesis, resolution, and biological evaluation of the four steroisomers of 4-methylglutamic acid: selective probes of kainate receptors. J. Med. Chem. 38:1995;2518-2520.
10. Hall R.A., Massicotte G., Kessler M., Baudry M., Lynch G. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states. Mol. Pharmacol. 43:1993;459-464.
11. Herb A., Burnashev N., Werner P., Sakmann B., Wisden W., Seeburg P.H. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron. 8:1992;775-785.
12. Hollmann M., Heinemann S. Cloned glutamate receptors. Ann. Rev. Neurosci. 17:1994;31-108.
13. Honoré T., Davies S.N., Drejer J., Fletcher E.J., Jacobsen P., Lodge D., Nielsen F.E. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 241:1988;701-703.
14. Hoo K., Nutt S., Fletcher E.F., Elliot C., Korczak B., Deverill M., Rampersand V., Fantaske R.P., Kamboj R.K. Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: a kainate selective channel subunit. Recept. Channels. 2:1994;327-337.
15. Howe J.R. Homomeric and heteromeric ion channels formed from the kainate-type subunits GluR6 and KA2 have very small, but different, unitary conductances. J. Neurophysiol. 76:1996;510-519.
16. Huettner J.E. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron. 5:1990;255-266.
17. Jane D.E., Hoo K., Kamboj R., Bleakman D., Mandelzys A. Synthesis of Willardiine and 6-Azawillardiine analogues: Pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J. Med. Chem. 40:1997;3645-3650.
18. Jones K.A., Wilding T.J., Huettner J.E., Costa A-M. Desensitization of kainate receptors by kainate, glutamate, and diasteromers of 4-methylglutamate. Neuropharmacology. 36:1997;853-863.
19. Korczak B., Nutt S.L., Fletcher E.J., Hoo K.H., Elliott C.E., Rampersand V., McWhinnie E.A., Kamboj R.K. cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. Recept. Channels. 3:1995;41-49.
20. Krogsgaard-Larsen P., Madsen U., Ebert B., Hansen J.J. Krogsgaard-Larsen P., Hansen J.J. Excitatory Amino Acid Receptors Design of Agonists and Antagonists. 1994;34-55 Ellis Horwood, London.
21. Lauridsen J., Honoré T., Krogsgaard-Larsen P. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors. J. Med. Chem. 28:1985;668-672.
22. O'Neill M.J., Bond A., Ornstein P.L., Ward M.A., Hicks C.A., Hoo K., Bleakman D., Lodge D. Decahydroisoquinolines; novel competitive AMPA/KA antagonists with neuroprotective effects in global cerebral ishemia. Neuropharmacology. 37:1998;1211-1222.
23. Partin K.M., Patneau D.K., Winters C.A., Mayer M.L., Buonanno A. Selective modulation of desensitization at AMPA receptors vs kainate receptors by cyclothiazide and concanavalin A. Neuron. 11:1993;1069-1082.
24. Sahara Y., Noro N., Iida Y., Soma K., Nakamura Y. Glutamate receptor subunits GluR5 and KA-2 are co-expressed in rat trigeminal ganglion neurons. J. Neurosci. 17:1997;6611-6620.
25. Schiffer H.H., Swanson G.T., Heinemann S.F. Rat GluR7 and carboxy-terminus splice variant, GluR7b, are functional kainate receptor subunits with low sensitivity to glutamate. Neuron. 19:1997;1141-1146.
26. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honoré T. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuro-protectant for cerebral ischemia. Science. 247:1990;571-574.
27. Simmons R.M., Li D.L., Deverill M., Ornstein P.L., Iyengar S. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology. 37:1998;25-36.
28. Small B.G., Thomas J., Kemp M., Hoo K., Ballyk B.A., Deverill M., Ogden A.M., Rubio A., Pedregal C., Bleakman D. LY339434, a GluR5 kainate receptor agonist. Neuropharmacology. 37:1998;1261-1267.
29. Sommer B., Köhler M., Sprengel R., Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate gated channels. Cell. 67:1992;11-19.
30. Sommer B., Burnashev N., Verdoorn T.A., Keinänen K., Sakmann B., Seeburg P.H. A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 11:1992;1651-1656.
31. Stensbol, et al. 1999 Resolution, absolute sterochemistry and molecular pharmacology of the enantiomers of (RS)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)proprionic acid (ATPA), a GluR5 agonist. Eur. J. Pharmacol. (in press).
32. Swanson G.T., Feldmeyer D., Kaneda M., Cull-Candy S.G. Effect of RNA editing and subunit co-assembly on single-channel properties of recombinant kainate receptors. J. Physiol. 492:1996;129-142.
33. Thomas N.K., Hawkins L.M., Miller J.C., Troop H.M., Roberts P.J., Jane D.E. Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurons and dorsal roots. Neuropharmacology. 37:1998;1223-1238.
34. 3H]-(2S,4R)-4-methylglutamate: pharmacological characterization in rabbit brain membranes. Neuropharmacology. 36:1997;1483-1488.
35. Zhou L-M, Gu Z-Q, Costa A.M., Yamada K.A., Mansson P.E., Giordano T., Skolnick P., Jones K.A (2S, 4R)-4-methylglutamic acid (SYM 2081): a selective, high affinity ligand for kainate receptors. J. Pharmacol. Exp. Ther. 280:1997;422-427.